CymitQuimica logo

L-371,257

CAS:

Ref. 3D-MGA04244

10mg
713.00€
25mg
1,194.00€
50mg
1,661.00€
L-371,257
Biosynth

    Product Information

    Name:L-371,257
    Controlled Product
    Brand:Biosynth
    Description:L-371,257 is a novel and potent oxytocin receptor antagonist. It prevents the activation of the oxytocin receptor by binding to it, thereby blocking the effects of oxytocin on the heart and other organs. L-371,257 has been shown to have a protective effect in animal models of cardiac hypertrophy and heart failure. In humans, L-371,257 has been shown to inhibit ventricular myocyte apoptosis induced by all-trans retinoic acid (ATRA) or beta-adrenergic stimulation. L-371,257 also prevents atosiban-induced pancreatic dysfunction in mice.L-371,257 is a compound that belongs to a class of drugs called antagonists that are used in scientific research for studying receptor activity. The drug binds reversibly to the target receptor and blocks its activity temporarily. This drug can be administered orally and has an analytical method using high performance liquid chromatography with ultraviolet detection at 254 nm.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:507.59 g/mol
    Formula:C28H33N3O6
    Purity:Min. 95%

    Technical inquiry about: L-371,257

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.